Oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in the Japanese population

European Journal of Endocrinology

Volumn 147, Issue 3, 2002, Pages 287-291

  Vanvooren, V ^a   Uchino, S ^a   Duprez, L ^a   Costa, M J ^a   Vandekerckhove, J ^a   Parma, J ^a   Vassart, G ^a   Dumont, J E ^a   Van Sande, J ^a   Noguchi, S ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; THYROTROPIN RECEPTOR;

ALPHA CHAIN; ARTICLE; CARCINOGENICITY; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; ENZYME ACTIVITY; EUROPE; FEMALE; FROZEN SECTION; GENE ACTIVATION; GENE AMPLIFICATION; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; GOITER; HUMAN; JAPAN; MALE; PATHOGENESIS; POPULATION RESEARCH; PRIORITY JOURNAL; SEQUENCE ANALYSIS; THYROID ADENOMA; THYROID NODULE;

EID: 0036740782     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1470287     Document Type: Article

References (28)

1. Dumont JE, Vassart G & Refetoff S. Thyroid disorders. In The Metabolic and Molecular Bases of Inherited Diseases, pp 1843-1879. Ed. CR Scriver. New York: McGraw-Hill, 1989.
2. Dumont JE, Lamy F, Roger P & Maenhaut C. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiological Reviews 1992 72 667-697.
3. Vassart G & Dumont JE. The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocrine Reviews 1992 13 596-611.
4. Dumont JE, Jauniaux JC & Roger PP. The cyclic AMP-mediated stimulation of cell proliferation. Trends in Biochemical Sciences 1989 14 67-71.
5. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J et al. Somatic mutations in the thyrotropin receptor gene cause hyper-functioning thyroid adenomas. Nature 1993 365 649-651.
6. Parma J, Duprez L, Van Sande J, Hermans J, Rocmans P, Van Vliet G et al. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas. Journal of Clinical Endocrinology and Metabolism 1997 82 2695-2701.
7. Porcellini A, Ciullo I, Laviola L, Amabile G, Fenzi G & Avvedimento VE. Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy. Journal of Clinical Endocrinology and Metabolism 1994 79 657-661.
8. Russo D, Arturi F, Suarez HG, Schlumberger M, Du Villard JA, Crocetti U et al. Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas. Journal of Clinical Endocrinology and Metabolism 1996 81 1548-1551.
9. Trulzsch B, Krohn K, Wonerow P, Chey S, Holzapfel HP, Ackermann F et al. Detection of thyroid-stimulating hormone receptor and Gsalpha mutations in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis. Journal of Molecular Medicine 2001 78 684-691.
10. Takeshita A, Nagayama Y, Yokoyama N, Ishikawa N, Ito K, Yamashita T et al. Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan. Journal of Clinical Endocrinology and Metabolism 1995 80 2607-2611.
11. Kosugi S, Hai N, Okamoto H, Sugawa H & Mori T. A novel activating mutation in the thyrotropin receptor gene in an autonomously functioning thyroid nodule developed by a Japanese patient. European Journal of Endocrinology 2000 143 471-477.
12. Tanaka K, Nagayama Y, Takeshita A, Namba H, Yamashita S, Niwa M et al. Low incidence of the stimulatory G protein alpha-subunit mutations in autonomously functioning thyroid adenomas in Japan. Thyroid 1996 6 195-199.
13. Tonacchera M, Cetani F, Parma J, Van Sande J, Vassart G & Dumont J. Oncogenic mutations in thyroid adenoma: methodological criteria. European Journal of Endocrinology 1996 135 444-446.
14. de Roux N, Polak M, Couet J, Leger J, Czernichow P, Milgrom E et al. A neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 1996 81 2023-2026.
15. 2+ cascades. Molecular Endocrinology 1995 9 725-733.
16. Spambalg D, Sharifi N, Elisei R, Gross JL, Medeiros-Neto G & Fagin JA. Structural studies of the thyrotropin receptor and Gs alpha in human thyroid cancers: low prevalence of mutations predicts infrequent involvement in malignant transformation. Journal of Clinical Endocrinology and Metabolism 1996 81 3898-3901.
17. Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtinger H et al. Two G protein oncogenes in human endocrine tumors. Science 1990 249 655-659.
18. Duprez L, Parma J, Costagliola S, Hermans J, Van Sande J, Dumont JE et al. Constitutive activation of the TSH receptor by spontaneous mutations affecting the N-terminal extracellular domain. FEBS Letters 1997 409 469-474.
19. Duprez L, Hermans J, Van Sande J, Dumont JE, Vassart G & Parma J. Two autonomous nodules of a patient with multi-nodular goiter harbor different activating mutations of the thyrotropin receptor gene. Journal of Clinical Endocrinology and Metabolism 1997 82 306-308.
20. Tonacchera M, Agretti P, Chiovato L, Rosellini V, Ceccarini G, Perri A et al. Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter. Journal of Clinical Endocrinology and Metabolism 2000 85 2270-2274.
21. Gabriel EM, Bergert ER, Grant CS, van Heerden JA, Thompson GB & Morris JC. Germline polymorphism of codon 727 of human thyroid-stimulating hormone receptor is associated with toxic multinodular goiter. Journal of Clinical Endocrinology and Metabolism 1999 84 3328-3335.
22. Holzapfel HP, Fuhrer D, Wonerow P, Weinland G, Scherbaum WA & Paschke R. Identification of constitutively activating somatic thyrotropin receptor mutations in a subset of toxic multinodular goiters. Journal of Clinical Endocrinology and Metabolism 1997 82 4229-4233.
23. Krohn K, Fuhrer D, Holzapfel HP & Paschke R. Clonal origin of toxic thyroid nodules with constitutively activating thyrotropin receptor mutations. Journal of Clinical Endocrinology and Metabolism 1998 83 130-134.
24. Derwahl M. Molecular aspects of the pathogenesis of nodular goiters, thyroid nodules and adenomas. Experimental and Clinical Endocrinology Diabetes 1996 104 (Suppl 4) 32-35.
25. Clement S, Refetoff S & Robaye B. Low TSH requirement and goiter in transgenic mice overexpressing IGF-I and IGF-I receptor in the thyroid gland. Endocrinology 2001 142 5131-5139.
26. Laurberg P, Nohr SB, Pedersen KM, Hreidarsson AB, Andersen S, Bulow Pedersen I et al. Thyroid disorders in mild iodine deficiency. Thyroid 2000 10 951-963.
27. Laurberg P, Pedersen KM, Vestergaard H & Sigurdsson G. High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves' disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. Journal of Internal Medicine 1991 229 415-420.
28. Als C & Rosler H. Toxic adenomas of the thyroid gland becoming less frequent in Berne. Schweizerische Medizinische Wochenschrift 1995 125 1495-1499.